Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study

Background. Adipocytokines participate in regulating the inflammatory response in glucose homeostasis and type 2 diabetes. However, among these peptides, the role of adipocyte-specific fatty-acid-binding protein (AFABP), chemerin, and secreted protein acidic and rich in cysteine (SPARC) in gestation...

Full description

Saved in:
Bibliographic Details
Main Authors: Maryam Mosavat, Mitra Mirsanjari, Bashir A. Lwaleed, Maherah Kamarudin, Siti Zawiah Omar
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2021/5533802
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550898185797632
author Maryam Mosavat
Mitra Mirsanjari
Bashir A. Lwaleed
Maherah Kamarudin
Siti Zawiah Omar
author_facet Maryam Mosavat
Mitra Mirsanjari
Bashir A. Lwaleed
Maherah Kamarudin
Siti Zawiah Omar
author_sort Maryam Mosavat
collection DOAJ
description Background. Adipocytokines participate in regulating the inflammatory response in glucose homeostasis and type 2 diabetes. However, among these peptides, the role of adipocyte-specific fatty-acid-binding protein (AFABP), chemerin, and secreted protein acidic and rich in cysteine (SPARC) in gestational diabetes (GDM) has not been fully investigated. Method. The maternal fasting level of adipocytokines of 53 subjects with GDM and 43 normal pregnant (NGDM) was measured using multiplex immunoassay at 24–28 weeks, before delivery, immediate postpartum, and 2–6 months postpuerperium. Results. Higher levels of AFABP were associated with a 3.7-fold higher risk of GDM. Low chemerin levels were associated with a 3.6-fold higher risk of GDM. Interleukin-10 (IL-10) was inversely associated with the risk of GDM. SPARC had no association with GDM. AFABP was directly correlated to interleukin-6 (r=0.50), insulin resistance index (r=0.26), and body mass index (r=0.28) and inversely correlated to C-reactive protein (r=−0.27). Chemerin levels were directly and strongly correlated with IL-10 (r=0.41) and interleukin-4 (r=0.50) and inversely correlated to insulin resistance index (r=−0.23) in GDM but not NGDM. In the longitudinal assessment, there were no significant differences in AFABP and chemerin concentrations of both studied groups. Conclusion. AFABP and chemerin were associated with a higher risk of GDM. These adipocytokines were related to insulin resistance, body mass index, and inflammation in pregnant women diagnosed with GDM.
format Article
id doaj-art-43a1125527974439b9c64ac5be1860cb
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-43a1125527974439b9c64ac5be1860cb2025-02-03T06:05:27ZengWileyJournal of Diabetes Research2314-67452314-67532021-01-01202110.1155/2021/55338025533802Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control StudyMaryam Mosavat0Mitra Mirsanjari1Bashir A. Lwaleed2Maherah Kamarudin3Siti Zawiah Omar4Department of Obstetrics & Gynecology, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaMazandaran University of Medical Sciences, Emam Khomeini Hospital, Fereidonkenar, Mazandaran, IranSchool of Health Sciences at the University of Southampton, UKDepartment of Obstetrics & Gynecology, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaDepartment of Obstetrics & Gynecology, Faculty of Medicine, University of Malaya, Kuala Lumpur, MalaysiaBackground. Adipocytokines participate in regulating the inflammatory response in glucose homeostasis and type 2 diabetes. However, among these peptides, the role of adipocyte-specific fatty-acid-binding protein (AFABP), chemerin, and secreted protein acidic and rich in cysteine (SPARC) in gestational diabetes (GDM) has not been fully investigated. Method. The maternal fasting level of adipocytokines of 53 subjects with GDM and 43 normal pregnant (NGDM) was measured using multiplex immunoassay at 24–28 weeks, before delivery, immediate postpartum, and 2–6 months postpuerperium. Results. Higher levels of AFABP were associated with a 3.7-fold higher risk of GDM. Low chemerin levels were associated with a 3.6-fold higher risk of GDM. Interleukin-10 (IL-10) was inversely associated with the risk of GDM. SPARC had no association with GDM. AFABP was directly correlated to interleukin-6 (r=0.50), insulin resistance index (r=0.26), and body mass index (r=0.28) and inversely correlated to C-reactive protein (r=−0.27). Chemerin levels were directly and strongly correlated with IL-10 (r=0.41) and interleukin-4 (r=0.50) and inversely correlated to insulin resistance index (r=−0.23) in GDM but not NGDM. In the longitudinal assessment, there were no significant differences in AFABP and chemerin concentrations of both studied groups. Conclusion. AFABP and chemerin were associated with a higher risk of GDM. These adipocytokines were related to insulin resistance, body mass index, and inflammation in pregnant women diagnosed with GDM.http://dx.doi.org/10.1155/2021/5533802
spellingShingle Maryam Mosavat
Mitra Mirsanjari
Bashir A. Lwaleed
Maherah Kamarudin
Siti Zawiah Omar
Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study
Journal of Diabetes Research
title Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study
title_full Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study
title_fullStr Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study
title_full_unstemmed Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study
title_short Adipocyte-Specific Fatty Acid-Binding Protein (AFABP) and Chemerin in Association with Gestational Diabetes: A Case-Control Study
title_sort adipocyte specific fatty acid binding protein afabp and chemerin in association with gestational diabetes a case control study
url http://dx.doi.org/10.1155/2021/5533802
work_keys_str_mv AT maryammosavat adipocytespecificfattyacidbindingproteinafabpandchemerininassociationwithgestationaldiabetesacasecontrolstudy
AT mitramirsanjari adipocytespecificfattyacidbindingproteinafabpandchemerininassociationwithgestationaldiabetesacasecontrolstudy
AT bashiralwaleed adipocytespecificfattyacidbindingproteinafabpandchemerininassociationwithgestationaldiabetesacasecontrolstudy
AT maherahkamarudin adipocytespecificfattyacidbindingproteinafabpandchemerininassociationwithgestationaldiabetesacasecontrolstudy
AT sitizawiahomar adipocytespecificfattyacidbindingproteinafabpandchemerininassociationwithgestationaldiabetesacasecontrolstudy